Handheld reflectance confocal microscopy with radial video mosaicing showed utility in mapping lentigo maligna and lentigo maligna melanoma.The prospective trial included patients with biopsy ...

The strongest predictor of lentigo maligna melanoma progression is histologic margin status, and patients with margins less than 3 mm should consider re-excision, according to a study.“Lentigo ...

A research team has developed a diagnostic system that uses artificial intelligence (AI) to accurately identify the type of facial pigmented lesions and support laser treatment decisions. A paper on ...

[8,17] The potential risk of an in situ lentigo maligna becoming an invasive melanoma is unknown. There are no long-term follow-up studies so the frequency of progression remains uncertain.

Discover a study showing how AI outperforms dermatologists in diagnosing facial pigmented lesions, supporting safer treatment decisions.

Often confirmed as lentigo maligna melanoma: Amelanotic/NMSC-like (CL3) • Diagnosis as malignant melanoma in situ: less likely • Diagnosis as nodular melanoma or other subtype: more likely ...

Sunday, April 20, 2025. News & Perspective Drugs & Diseases CME & Education Video Decision Point close ...

A research team led by Haruyo Yamamoto, Chisa Nakashima, and Atsushi Otsuka from Department of Dermatology, Faculty of ...

For patients with lentigo maligna (LM) in-situ melanoma, topical imiquimod has a pathological complete regression (pCR) rate of 37%, according to a study published online in the British Journal of ...

Ingenol mebutate to treat lentigo maligna of the head (face and scalp): A prospective and multicenter single-arm phase 2 trial. Henri Montaudié , Florence Le Duff , Catherine Butori , Veronique Hofman ...

Unlike other types of lentigo, lentigo simplex can appear at birth or in childhood. The spots don’t cause pain or itchiness and are benign, meaning that they don’t develop into skin cancer.